SELECTA BIOSCI. DL -,0001
SELECTA BIOSCI. DL -,0001
Aktie · US8162121045 · SELB · A2AML0 (LSSI)
Übersicht Finanzkennzahlen
Kein Kurs
n/a
1 Tag
-
1 Woche
-
1 Monat
-
3 Monate
-
6 Monate
-
Jahr bis heute
-
1 Jahr
-
2 Jahre
-
3 Jahre
-
4 Jahre
-
5 Jahre
-
10 Jahre
-
20 Jahre
-
Max
-
Analyst Grade Summary
gauge-img
Kaufen
Starker Kauf
Kaufen
Halten
Verkaufen
Starker Verkauf
0
10
1
0
0
Aktuelle Kurse von SELECTA BIOSCI. DL -,0001
BörseTickerWährungLetzter UmsatzKursTagesveränderung
XNAS: NASDAQ
NASDAQ
SELB
USD
13.11.2023 21:00
0,88 USD
-
Free Float & Liquidität
Free Float 61,26 EUR
Shares Float 94 M EUR
Ausstehende Aktien 153,43 M EUR
Investierte Fonds

Folgende Fonds haben in SELECTA BIOSCI. DL -,0001 investiert:

Fonds
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vol. in Mio
15,70
Anteil (%)
0,04 %
Firmenprofil zu SELECTA BIOSCI. DL -,0001 Aktie
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. It is also developing biologic therapies, such as SEL-212 that is in Phase III clinical trials for the treatment of chronic refractory gout; and product candidates to treat IgA-mediated diseases, including IgA nephropathy, linear IgA bullous dermatitis, IgA pemphigus, and Henoch-Schonlein purpura. In addition, the company is developing gene therapies comprising SEL-313, a product candidate in preclinical stage to treat ornithine transcarbamylase deficiency; SEL-399, a product candidate to evaluate the appropriate dose of ImmTOR in humans to reduce the formation of antibodies to AAV capsids; and products for the treatment of pompe disease, duchenne muscular dystrophy, limb-girdle muscular dystrophy, lysosomal storage disorder, and other autoimmune diseases. Further, it develops tolerogenic therapies to treat primary biliary cholangitis and other autoimmune diseases. The company has license and collaboration agreements with Takeda Pharmaceuticals USA, Inc.; Swedish Orphan Biovitrum; Sarepta Therapeutics, Inc.; Asklepios Biopharmaceutical, Inc.; Massachusetts Institute of Technology; Shenyang Sunshine Pharmaceutical Co., Ltd.; Ginkgo Bioworks Holdings, Inc.; and IGAN Biosciences, Inc. Selecta Biosciences, Inc. was incorporated in 2007 and is headquartered in Watertown, Massachusetts.

Unternehmensdaten

Name SELECTA BIOSCI. DL -,0001
Firma Selecta Biosciences, Inc.
Symbol SELB
Website https://selectabio.com
Heimatbörse LSSI Lang & Schwarz
WKN A2AML0
ISIN US8162121045
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Carsten Brunn
Marktkapitalisierung 135 Mio
Land Vereinigte Staaten von Amerika
Währung EUR
Mitarbeiter 0,1 T
Adresse 65 Grove Street, 02472 Watertown
IPO Datum 2016-06-22

Ticker Symbole

Name Symbol
NASDAQ SELB
Weitere Aktien
Investoren, die SELECTA BIOSCI. DL -,0001 halten, haben auch folgende Aktien im Depot:
AMGEN INC
AMGEN INC Aktie
AMUNDI INDEX BARCLAYS US CORPBBB 1-5 - IU (C)
AMUNDI INDEX BARCLAYS US CORPBBB 1-5 - IU (C) ETF
AUTODESK INC
AUTODESK INC Aktie
AUTOMATIC DATA PROCESSING INC
AUTOMATIC DATA PROCESSING INC Aktie
CISCO SYSTEMS INC
CISCO SYSTEMS INC Aktie
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Aktie
FIRST TRUST CAPITAL STRENGTH ETF
FIRST TRUST CAPITAL STRENGTH ETF ETF
HONEYWELL INTERNATIONAL INC
HONEYWELL INTERNATIONAL INC Aktie
Hongda Xingye Co., Ltd.
Hongda Xingye Co., Ltd. Aktie
INTEL CORP
INTEL CORP Aktie
MICROSOFT CORP
MICROSOFT CORP Aktie
PICTET-INDIAN EQS NAM.PDL
PICTET-INDIAN EQS NAM.PDL Fonds
QIAGEN NV (alt)
QIAGEN NV (alt) Aktie
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Aktie
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025